Use the hyperlinks, where available to access additional clinical trial information.
CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination With Abiraterone Plus Prednisone in Men With High-Risk Metastatic Hormone-Sensitive Prostate Cancer
Eli Lilly and Company
Eligible participants will be randomly allocated to either the Experimental Arm or Active Comparator Arm. In the Experimental Arm, participants will receive abemaciclib + abiraterone + prednisone/prednisolone, all administered orally. In the Active Comparator Arm, participants will receive a placebo for abemaciclib + abiraterone + prednisone/prednisolone, all administered orally.